Primary brain lymphoma (PLBHL) is a rare and aggressive malignancy that arises from lymphoid tissue in the brain. It, along with other secondary tumors that cause neurologic symptoms, is a form of primary central nervous system (CNS) tumor. PLBHL is typically identified in immunocompromised patients, although it can also occur in immunocompetent individuals. Clinically, the disease can present with a variety of neurologic symptoms depending on the tumor location, such as headaches, behavioral changes, residual neurologic symptoms, and seizures. PLBHL can have different subtypes, including diffuse large cell lymphoma (DCL), which is the most common of the group, and less common variants such as follicular lymphomas.
History of the disease and interesting historical facts
Primary brain lymphoma was first described in the medical literature in the mid-20th century, but archaeological evidence suggests that lymphoma-like conditions existed in ancient times. In 1972, a classification was proposed that differentiated lymphomas arising in the central nervous system from other tumors of this region. Interestingly, during World War II, there was an increase in the incidence of PLHM among soldiers, which has been linked to many stress factors, as well as various infections, including the Epstein-Barr virus, which has been implicated as a potential culprit. By the 1990s, new imaging techniques became available that allowed for more effective diagnosis of brain lymphomas.
Epidemiology
According to global studies, the incidence of primary brain lymphoma is approximately 0.4-0.5 cases per 100,000 people per year. The disease is most common in patients with HIV infection and other immunodeficiency states. Patients with organ transplants and specific autoimmune diseases are at risk. PLHM occurs more often in men than in women, with a ratio of about 2:1. Age factors also play a role in the development of the disease, since the greatest number of cases occur in people over 60 years of age, although it can also occur in disabled people aged 20-30 years. According to statistics, the incidence in the elderly shows a significant increase, which may be due to a weakening of the immune system and age-related changes in the body.
Genetic predisposition to this disease
Genetic markers associated with primary brain lymphoma are often the result of mutational changes that lead to cell cycle and apoptosis dysregulation. The most important genes involved are TP53, BCL6, and MYC. High expression of BCL6 is associated with poor prognosis and an aggressive form of the disease. This indicates a possible genetic predisposition to the development of PHL in the context of mutations or polymorphisms of these key genes. Some studies also note an association with the Epstein-Barr virus, which can encapsulate in lymphocytes and promote the development of malignant cells.
Risk factors for the development of this disease
Primary brain lymphoma has several risk factors that may contribute to its development. These include:
- Immunodeficiency: relationship with HIV infection, organ transplantation, autoimmune diseases.
- Infectious diseases: presence of Epstein-Barr virus.
- Age: Higher incidence among people over 60 years of age.
- Gender: Increased incidence in males compared to females.
- Environmental influences: exposure of the body to certain chemicals.
In addition to these factors, it is noted that certain lifestyle and hereditary predisposition can also influence the risk of developing PGM.
Diagnosis of this disease
Diagnosis of primary brain lymphoma involves several steps, starting with clinical evaluation and ending with specialized laboratory and radiological studies. The main symptoms of the disease may include:
- Headaches that gradually increase over time.
- Convulsions and epileptic seizures.
- Cognitive disturbances, including changes in personality and behavior.
- Neurological deficits such as motor or sensory impairments.
Laboratory tests are performed to confirm the diagnosis, including cerebrospinal fluid analysis, which can detect the presence of malignant cells and markers specific to lymphoma. Radiological studies, such as MRI and CT of the brain, help to visualize the tumor and assess its size and extent. A biopsy is also necessary for final verification of the diagnosis. The differential diagnosis method includes excluding other tumors, such as metastatic processes or infections.
Treatment
Treatment of primary brain lymphoma combines various approaches, including pharmacological treatment, surgery and radiation therapy. The main line of pharmacological treatment is based on chemotherapy using high-intensity regimens such as CHOP (Cyclophosphamide, Doxorubicin, Vincristine, Prednisone) or single-agent methotrexate. Surgery may be performed to remove the tumor, especially when possible and necessary to relieve symptoms. Radiation therapy is often used after chemotherapy to reduce the risk of relapse. In some cases, newer methods such as immunotherapy and checkpoint inhibitors are used.
List of medications used to treat this disease
Medications used to treat primary brain lymphoma include:
- Methotrexate
- Cyclophosphamide
- Doxorubicin
- Vincristine
- Prednisone
- Rituximab
- Levamisole
These drugs can be used both as independent therapy and as part of combination treatment.
Disease monitoring
Monitoring the patient’s condition after treatment for primary brain lymphoma is important to assess the effectiveness of therapy and detect possible relapses. Monitoring steps include regular imaging studies, such as MRI, as well as clinical observation of symptoms. The prognosis for this disease depends on many factors, including the patient’s age, overall health, response to treatment, and the extent of the tumor at diagnosis. Potential complications may include relapses of the disease, loss of cognitive function, and neurological deficits, which require highly skilled medical care and rehabilitation.
Age-related features of the disease
Primary brain lymphoma can present differently depending on the patient’s age group. It is less common in children and adolescents, but tends to be more aggressive and requires immediate intervention. Adults, particularly those over 60, have an increased risk of developing the disease, but may also respond more favorably to chemotherapy. In older people, the main challenge is the presence of comorbidities, which may influence the choice of treatment approach.
Questions and Answers
- What are the main symptoms of primary brain lymphoma? Major symptoms include headaches, seizures, changes in cognitive function and neurological deficits.
- How is primary brain lymphoma diagnosed? Diagnosis includes clinical examination, MRI/CT, cerebrospinal fluid analysis and biopsy.
- What is the prognosis for primary brain lymphoma? The prognosis depends on the stage of the disease, the patient's age and response to treatment.
- What treatment methods are used for this disease? Treatment includes chemotherapy, radiotherapy and surgery.
- What is the relationship between Epstein-Barr virus and primary brain lymphoma? Epstein-Barr virus is considered a risk factor for the development of this disease, especially in immunocompromised patients.
